The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
EMT: Present and future in clinical oncology
Open accessAbstract
Epithelial/mesenchymal transition (EMT) has emerged as a key regulator of metastasis by facilitating tumor cell invasion and dissemination to distant organs. Recent evidences support that the reverse mesenchymal/epithelial transition (MET) is required for metastatic outgrowth; moreover, the existence of hybrid epithelial/mesenchymal (E/M) phenotypes is increasingly being reported in different tumor contexts. The accumulated data strongly support that plasticity between epithelial and mesenchymal states underlies the dissemination and metastatic potential of carcinoma cells. However, the translation into the clinics of EMT and epithelial plasticity processes presents enormous challenges and still remains a controversial issue. In this review, we will evaluate current evidences for translational applicability of EMT and depict an overview of the most recent EMT in vivo models, EMT marker analyses in human samples as well as potential EMT therapeutic approaches and ongoing clinical trials. We foresee that standardized analyses of EMT markers in solid and liquid tumor biopsies in addition to innovative tools targeting the E/M states will become promising strategies for future translation to the clinical setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302 · cited 1×
“Besides, deregulated expression of canonical EMT-TFs has been associated with several tumor types, especially those displaying EMT such as breast, cervix, ovary, or colon (reviewed in De Craene and Berx, 2013; Peinado et al., 2007; Polyak and Weinberg, 2009; Steinestel et al., 2014).”
BackgroundSnail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121 · cited 7×
“, alternative splicing, noncoding RNAs, epigenetic regulatory mechanisms, protein stability) (De Craene and Berx, 2013; Diaz-Lopez et al., 2014; Nieto, 2011; Nieto and Cano, 2012; Peinado et al., 2007; Tam and Weinberg, 2013; Yang and Weinberg, 2008).”
BackgroundInfluentialEmerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,441
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299 · cited 5×
“In this line, downregulation or loss of function of proteins involved in epithelial homeostasis such as tight junction components [claudins, occludins, ZO-1 (zonula occludens-1)] is frequently observed in several carcinomas (Steinestel et al., 2014; Zeisberg and Neilson, 2009), whereas the expression shift from epithe…”
BackgroundInfluentialEMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136 · cited 5×
“One of the first animal model described, based on the mouse model of PDAC, allowed the detection of migrating and invading tumor cells by the yellow fluorescent protein (YFP) tracer (Rhim et al., 2012).”
BackgroundResultInfluentialZheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Labelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
Fischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Epithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704
E-cadherin germline mutations in familial gastric cancer
Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A., & Reeve, A. E. (1998) · Nature · doi:10.1038/32918 · Cited by 1,656
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Morel, A.-P., Lièvre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002888 · Cited by 1,645
Vimentin in cancer and its potential as a molecular target for cancer therapy
Satelli, A., & Li, S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0735-1 · Cited by 1,557
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401 · cited 2×
“(2015) is that they allow the detection of cells undergoing a full EMT, due to the restricted expression of the Fsp1 (fibroblast-specific protein 1) promoter to mesenchymal cells (Bhowmick et al., 2004), but might underestimate the detection of intermediate E/M states during the course of tumor cell dissemination.”
BackgroundMigrating cancer stem cells — an integrated concept of malignant tumour progression
Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., & Kirchner, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1694 · Cited by 1,352
The epigenetics of epithelial-mesenchymal plasticity in cancer
Tam, W. L., & Weinberg, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3336 · Cited by 1,163
Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S., & Yang, J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.022 · Cited by 1,071
Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
Sarrió, D., Rodriguez-Pinilla, S. M., Hardisson, D., Cano, A., Moreno-Bueno, G., & Palacios, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2017 · Cited by 1,056
Self-citationTaube, J. H., Herschkowitz, J. I., Komurov, K., Zhou, A. Y., Gupta, S., Yang, J., Hartwell, K., Onder, T. T., Gupta, P. B., Evans, K. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004900107 · Cited by 1,041
Krebs, A. M., Mitschke, J., Lasierra Losada, M., Schmalhofer, O., Boerries, M., Busch, H., Boettcher, M., Mougiakakos, D., Reichardt, W., Bronsert, P., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3513 · Cited by 975
Ocaña, O. H., Córcoles, R., Fabra, Á., Moreno-Bueno, G., Acloque, H., Vega, S., Barrallo-Gimeno, A., Cano, A., & Nieto, M. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.012 · Cited by 973
Self-citationEpithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
Nieto, M. A. (2013) · Science · doi:10.1126/science.1234850 · Cited by 967
Beg, M. S., Brenner, A. J., Sachdev, J., Borad, M., Kang, Y.-K., Stoudemire, J., Smith, S., Bader, A. G., Kim, S., & Hong, D. S. (2017) · Investigational New Drugs · doi:10.1007/s10637-016-0407-y · Cited by 897
Hennessy, B. T., Gonzalez-Angulo, A.-M., Stemke-Hale, K., Gilcrease, M. Z., Krishnamurthy, S., Lee, J.-S., Fridlyand, J., Sahin, A., Agarwal, R., Joy, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3441 · Cited by 874
EMT, cell plasticity and metastasis
Chaffer, C. L., San Juan, B. P., Lim, E., & Weinberg, R. A. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9648-7 · Cited by 861
Bidard, F.-C., Peeters, D. J., Fehm, T., Nolé, F., Gisbert-Criado, R., Mavroudis, D., Grisanti, S., Generali, D., Garcia-Saenz, J. A., Stebbing, J., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70069-5 · Cited by 838
Serrano-Gomez, S. J., Maziveyi, M., & Alahari, S. K. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0502-x · Cited by 814
Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Du, B., & Shim, J. (2016) · Molecules · doi:10.3390/molecules21070965 · Cited by 807
The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?
Brabletz, S., & Brabletz, T. (2010) · EMBO reports · doi:10.1038/embor.2010.117 · Cited by 793
Tan, T. Z., Miow, Q. H., Miki, Y., Noda, T., Mori, S., Huang, R. Y., & Thiery, J. P. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404208 · Cited by 792
E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
Schmalhofer, O., Brabletz, S., & Brabletz, T. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9179-y · Cited by 765
Cheung, K. J., Padmanaban, V., Silvestri, V., Schipper, K., Cohen, J. D., Fairchild, A. N., Gorin, M. A., Verdone, J. E., Pienta, K. J., Bader, J. S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508541113 · Cited by 735
Epithelial–mesenchymal transition in tumor metastasis
Yeung, K. T., & Yang, J. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12017 · Cited by 723
The Ins and Outs of the Epithelial to Mesenchymal Transition in Health and Disease
Nieto, M. A. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154036 · Cited by 720
A microfluidic device for label-free, physical capture of circulating tumor cell clusters
Sarioglu, A. F., Aceto, N., Kojic, N., Donaldson, M. C., Zeinali, M., Hamza, B., Engstrom, A., Zhu, H., Sundaresan, T. K., Miyamoto, D. T., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3404 · Cited by 709
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
Ye, X., Tam, W. L., Shibue, T., Kaygusuz, Y., Reinhardt, F., Ng Eaton, E., & Weinberg, R. A. (2015) · Nature · doi:10.1038/nature14897 · Cited by 694
Kurrey, N. K., Jalgaonkar, S. P., Joglekar, A. V., Ghanate, A. D., Chaskar, P. D., Doiphode, R. Y., & Bapat, S. A. (2009) · Stem Cells · doi:10.1002/stem.154 · Cited by 655
Armstrong, A. J., Marengo, M. S., Oltean, S., Kemeny, G., Bitting, R. L., Turnbull, J. D., Herold, C. I., Marcom, P. K., George, D. J., & Garcia-Blanco, M. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0490 · Cited by 646
Korpal, M., Ell, B. J., Buffa, F. M., Ibrahim, T., Blanco, M. A., Celià-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2401 · Cited by 636
To differentiate or not — routes towards metastasis
Brabletz, T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3265 · Cited by 623
Correlation of Snail expression with histological grade and lymph node status in breast carcinomas
Blanco, M. J., Moreno-Bueno, G., Sarrio, D., Locascio, A., Cano, A., Palacios, J., & Nieto, M. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205416 · Cited by 576
Self-citationMechanism of early dissemination and metastasis in Her2+ mammary cancer
Harper, K. L., Sosa, M. S., Entenberg, D., Hosseini, H., Cheung, J. F., Nobre, R., Avivar-Valderas, A., Nagi, C., Girnius, N., Davis, R. J., et al. (2016) · Nature · doi:10.1038/nature20609 · Cited by 562
Transcriptional regulation of cadherins during development and carcinogenesis
Peinado, H., Portillo, F., & Cano, A. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041794hp · Cited by 561
Self-citationThe Fallacy of Epithelial Mesenchymal Transition in Neoplasia
Tarin, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0699 · Cited by 531
Katoh, Y., & Katoh, M. (2009) · Current Molecular Medicine · doi:10.2174/156652409789105570 · Cited by 525
Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll, R., Mitze, M., Frixen, U. H., & Birchmeier, W. (1993) · PubMed · Cited by 520
Yauch, R. L., Januario, T., Eberhard, D. A., Cavet, G., Zhu, W., Fu, L., Pham, T. Q., Soriano, R., Stinson, J., Seshagiri, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1492 · Cited by 495
Role of EMT in Metastasis and Therapy Resistance
Smith, B., & Bhowmick, N. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020017 · Cited by 484
Spaderna, S., Schmalhofer, O., Hlubek, F., Berx, G., Eger, A., Merkel, S., Jung, A., Kirchner, T., & Brabletz, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.016 · Cited by 476
Epithelial–mesenchymal transition (EMT) and metastasis: yes, no, maybe?
Diepenbruck, M., & Christofori, G. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.06.002 · Cited by 475
Berx, G., Cleton-Jansen, A., Strumane, K., de Leeuw, W. J., Nollet, F., Roy, F. M. V., & Cornelisse, C. J. (1996) · PubMed · Cited by 461
Celià-Terrassa, T., Meca-Cortés, Ó., Mateo, F., Martínez de Paz, A., Rubio, N., Arnal-Estapé, A., Ell, B. J., Bermudo, R., Díaz, A., Guerra-Rebollo, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59218 · Cited by 450
Stability of the hybrid epithelial/mesenchymal phenotype
Jolly, M. K., Tripathi, S. C., Jia, D., Mooney, S. M., Celiktas, M., Hanash, S. M., Mani, S. A., Pienta, K. J., Ben-Jacob, E., & Levine, H. (2016) · Oncotarget · doi:10.18632/oncotarget.8166 · Cited by 436
Gamallo, C., Palacios, J., Suarez, A., Pizarro, Á., Navarro, P., Quintanilla, M., & Cano, A. (1993) · PubMed · Cited by 410
Self-citationSaxena, M., Stephens, M. A., Pathak, H., & Rangarajan, A. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.61 · Cited by 408
EMT and MET in Metastasis: Where Are the Cancer Stem Cells?
Brabletz, T. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.11.009 · Cited by 403
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
Janni, W. J., Rack, B., Terstappen, L. W. M. M., Pierga, J.-Y., Taran, F.-A., Fehm, T., Hall, C., de Groot, M. R., Bidard, F.-C., Friedl, T. W. P., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1603 · Cited by 363
Beerling, E., Seinstra, D., de Wit, E., Kester, L., van der Velden, D., Maynard, C., Schäfer, R., van Diest, P., Voest, E., van Oudenaarden, A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.034 · Cited by 357
MiR-200, a new star miRNA in human cancer
Feng, X., Wang, Z., Fillmore, R., & Xi, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.11.004 · Cited by 342
Epithelial–mesenchymal transition: a new target in anticancer drug discovery
Marcucci, F., Stassi, G., & De Maria, R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.13 · Cited by 342
Zhou, P., Li, B., Liu, F., Zhang, M., Wang, Q., Liu, Y., Yao, Y., & Li, D. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0624-9 · Cited by 337
Distinctive properties of metastasis-initiating cells
Celià-Terrassa, T., & Kang, Y. (2016) · Genes & Development · doi:10.1101/gad.277681.116 · Cited by 336
Kajita, M., McClinic, K. N., & Wade, P. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7559-7566.2004 · Cited by 333
Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles
Li, J., Ai, Y., Wang, L., Bu, P., Sharkey, C. C., Wu, Q., Wun, B., Roy, S., Shen, X., & King, M. R. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.046 · Cited by 313
The Regulatory Role of MicroRNAs in EMT and Cancer
Zaravinos, A. (2015) · Journal of Oncology · doi:10.1155/2015/865816 · Cited by 291
Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
Wu, S., Liu, S., Liu, Z., Huang, J., Pu, X., Li, J., Yang, D., Deng, H., Yang, N., & Xu, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123976 · Cited by 282
Acs, G., Lawton, T. J., Rebbeck, T. R., LiVolsi, V. A., & Zhang, P. J. (2001) · American Journal of Clinical Pathology · doi:10.1309/fdhx-l92r-batq-2ge0 · Cited by 280
Embryonic stem cell markers expression in cancers
Schoenhals, M., Kassambara, A., Vos, J. D., Hose, D., Moreaux, J., & Klein, B. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.156 · Cited by 265
Hong, T., Watanabe, K., Ta, C. H., Villarreal-Ponce, A., Nie, Q., & Dai, X. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004569 · Cited by 265
Nieto, M. A., & Cano, A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.05.003 · Cited by 262
Self-citationHundal, H. S. (1992) · Endocrinology · doi:10.1210/en.131.3.1165 · Cited by 243
Transient SNAIL1 Expression Is Necessary for Metastatic Competence in Breast Cancer
Tran, H. D., Luitel, K., Kim, M., Zhang, K., Longmore, G. D., & Tran, D. D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0923 · Cited by 233
Metastasis: new functional implications of platelets and megakaryocytes
Leblanc, R., & Peyruchaud, O. (2016) · Blood · doi:10.1182/blood-2016-01-636399 · Cited by 231
Meidhof, S., Brabletz, S., Lehmann, W., Preca, B., Mock, K., Ruh, M., Schüler, J., Berthold, M., Weber, A., Burk, U., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404396 · Cited by 229
Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma
Castilla, M. Á., Moreno‐Bueno, G., Romero‐Pérez, L., De Vijver, K. V., Biscuola, M., López‐García, M. Á., Prat, J., Matías‐Guiu, X., Cano, A., Oliva, E., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2802 · Cited by 226
Self-citationThe morphological and molecular features of the epithelial-to-mesenchymal transition
Moreno-Bueno, G., Peinado, H., Molina, P., Olmeda, D., Cubillo, E., Santos, V., Palacios, J., Portillo, F., & Cano, A. (2009) · Nature Protocols · doi:10.1038/nprot.2009.152 · Cited by 221
Self-citationStankic, M., Pavlovic, S., Chin, Y., Brogi, E., Padua, D., Norton, L., Massagué, J., & Benezra, R. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.014 · Cited by 221
Expression of Snail protein in tumor–stroma interface
Francí, C., Takkunen, M., Dave, N., Alameda, F., Gómez, S., Rodríguez, R., Escrivà, M., Montserrat-Sentís, B., Baró, T., Garrido, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209519 · Cited by 220
Circulating tumor cells: clinical validity and utility
Cabel, L., Proudhon, C., Gortais, H., Loirat, D., Coussy, F., Pierga, J.-Y., & Bidard, F.-C. (2017) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1105-2 · Cited by 219
Garg, M. (2013) · World Journal of Stem Cells · doi:10.4252/wjsc.v5.i4.188 · Cited by 209
Sarrió, D., Pérez-Mies, B., Hardisson, D., Moreno-Bueno, G., Suárez, A., Cano, A., Martín-Pérez, J., Gamallo, C., & Palacios, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207439 · Cited by 208
Self-citationMorel, A.-P., Hinkal, G. W., Thomas, C., Fauvet, F., Courtois-Cox, S., Wierinckx, A., Devouassoux-Shisheboran, M., Treilleux, I., Tissier, A., Gras, B., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002723 · Cited by 207
Metformin in Breast Cancer: Time for Action
Goodwin, P. J., Ligibel, J. A., & Stambolic, V. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1630 · Cited by 200
Harouaka, R., Kang, Z., Zheng, S.-Y., & Cao, L. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.004 · Cited by 195
Gomis, R. R., & Gawrzak, S. (2017) · Molecular Oncology · doi:10.1016/j.molonc.2016.09.009 · Cited by 186
Watanabe, K., Villarreal-Ponce, A., Sun, P., Salmans, M. L., Fallahi, M., Andersen, B., & Dai, X. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.03.006 · Cited by 185
Oligonucleotide therapies for disorders of the nervous system
Khorkova, O., & Wahlestedt, C. (2017) · Nature Biotechnology · doi:10.1038/nbt.3784 · Cited by 179
Clinical significance of epithelial‐mesenchymal transition
Steinestel, K., Eder, S., Schrader, A. J., & Steinestel, J. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-17 · Cited by 177
Mh, Y., Chang, S.-Y., Chiou, S.-H., Liu, C.-J., Cw, C., Pm, C., Teng, S.-C., & Kj, W. (2006) · Oncogene · doi:10.1038/sj.onc.1209929 · Cited by 167
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives
Cano, A., Diaz-Lopez, A., & Moreno-Bueno, G. (2014) · Cancer Management and Research · doi:10.2147/cmar.s38156 · Cited by 165
Self-citationMetastatic Progression of Prostate Cancer and E-Cadherin
Putzke, A. P., Ventura, A. P., Bailey, A. M., Akture, C., Opoku‐Ansah, J., Çeliktaş, M., Hwang, M. S., Darling, D. S., Coleman, I. M., Nelson, P. S., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.028 · Cited by 162
Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs
Rowe, R. G., Li, X.-Y., Hu, Y., Saunders, T. L., Virtanen, I., de Herreros, A. G., Becker, K.-F., Ingvarsen, S., Engelholm, L. H., Bommer, G. T., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200810113 · Cited by 161
Li, Y., Xu, S.-C., Li, J., Han, K.-Q., Pi, H.-F., Zheng, L., Zuo, G.-H., Huang, X.-B., Li, H.-Y., Zhao, H.-Z., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.347 · Cited by 159
Epigenetic regulation of epithelial–mesenchymal transition
Sun, L., & Fang, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2303-1 · Cited by 159
Hsu, D. S., Lan, H., Huang, C.-H., Tai, S., Chang, S., Tsai, T.-L., Chang, C., Tzeng, C., Wu, K.-J., Kao, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0593 · Cited by 157
Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition
WILSON, C. A., Nicholes, K., Bustos, D. J., Lin, E., Song, Q., Stéphan, J.-P., Kirkpatrick, D. S., & Settleman, J. (2014) · Oncotarget · doi:10.18632/oncotarget.2397 · Cited by 155
Shiota, M., Zardan, A., Takeuchi, A., Kumano, M., Beraldi, E., Naito, S., Zoubeidi, A., & Gleave, M. E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0254 · Cited by 153
Epithelial-mesenchymal plasticity in circulating tumor cells
Alix‐Panabières, C., Mader, S., & Pantel, K. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1500-6 · Cited by 150
Chanrion, M., Kuperstein, I., Barrière, C., Marjou, F. E., Cohen, D., Vignjevic, D. M., Stimmer, L., Paul‐Gilloteaux, P., Bièche, I., Tavares, S. D. R., et al. (2014) · Nature Communications · doi:10.1038/ncomms6005 · Cited by 147
Pan‐cancer survey of epithelial–mesenchymal transition markers across the Cancer Genome Atlas
Gibbons, D. L., & Creighton, C. J. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24485 · Cited by 146
Barrière, G., Fici, P., Gallerani, G., Fabbri, F., Zoli, W., & Rigaud, M. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.10.04 · Cited by 142
Ledford, H. K. (2011) · Nature · doi:10.1038/472273a · Cited by 135
Analysis of the E-Cadherin Repressor Snail in Primary Human Cancers
Becker, K., Rosivatz, E., Blechschmidt, K., Kremmer, E., Sarbia, M., & Höfler, H. (2007) · Cells Tissues Organs · doi:10.1159/000101321 · Cited by 134
Chui, M. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27745 · Cited by 132
A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis
Takemoto, A., Okitaka, M., Takagi, S., Takami, M., Sato, S., Nishio, M., Okumura, S., & Fujita, N. (2017) · Scientific Reports · doi:10.1038/srep42186 · Cited by 131
Zhang, W., Feng, M., Zheng, G., Chen, Y., Wang, X., Pen, B., Yin, J., Yu, Y., & He, Z. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.142 · Cited by 130
Atzori, F., Tabernero, J. M., Cervantes, A. M. R., Prudkin, L., Andreu, J., Rodríguez-Braun, E., Domingo, A., Guijarro, J., Cenzano, C. G., Rodon, J. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3336 · Cited by 129
Genetic engineering of platelets to neutralize circulating tumor cells
Li, J., Sharkey, C. C., Wun, B., Liesveld, J. L., & King, M. R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.036 · Cited by 129
Huang, J., Wang, K., Xu, J., Huang, J., & Zhang, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078070 · Cited by 123
Della Corte, C. M., Bellevicine, C., Vicidomini, G., Vitagliano, D., Malapelle, U., Accardo, M., Fabozzi, A., Fiorelli, A., Fasano, M., Papaccio, F., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3319 · Cited by 122 · cited 1×
“Moreover, the resistance phenotype observed in NSCLC patients treated with c-MET and EGFR (EGF receptor) tyrosine kinase inhibitors is associated with ZEB1 expression (Della Corte et al., 2015; Rastogi et al., 2016).”
BackgroundEpigenetic control of epithelial-mesenchymal-transition in human cancer
Kiesslich, T., Pichler, M., & Neureiter, D. (2012) · Molecular and Clinical Oncology · doi:10.3892/mco.2012.28 · Cited by 122
OVOL guides the epithelial-hybrid-mesenchymal transition
Jia, D., Jolly, M. K., Boareto, M., Parsana, P., Mooney, S. M., Pienta, K. J., Levine, H., & Ben‐Jacob, E. (2015) · Oncotarget · doi:10.18632/oncotarget.3623 · Cited by 122
İmani, S., Hosseinifard, H., Cheng, J., Wei, C., & Fu, J. (2016) · Scientific Reports · doi:10.1038/srep28587 · Cited by 122
Tang, Y., Tang, Y., & Cheng, Y.-S. (2017) · Scientific Reports · doi:10.1038/srep38232 · Cited by 118
MicroRNAs as therapeutic targets in human cancers
Shah, M., & Calin, G. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1229 · Cited by 113
Alonso‐Alconada, L., Muinelo‐Romay, L., Madissoo, K., Díaz‐López, A., Krakstad, C., Trovik, J., Wik, E., Hapangama, D. K., Coenegrachts, L., Cano, A., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-223 · Cited by 103
Self-citationBezawy, R. E., Cominetti, D., Fenderico, N., Zuco, V., Beretta, G. L., Dugo, M., Arrighetti, N., Stucchi, C., Rancati, T., Valdagni, R., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.033 · Cited by 100
Epithelial to Mesenchymal Transition in a Clinical Perspective
Pasquier, J., Abu-Kaoud, N., Thani, H. A., & Rafii, A. (2015) · Journal of Oncology · doi:10.1155/2015/792182 · Cited by 98
Way, T., Huang, J.-T., Chou, C.-H., Huang, C.-H., Yang, M., & Ho, C. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.09.025 · Cited by 94
Pérez‐Losada, J., Sánchez‐Martín, M., Pérez-Caro, M., Pérez-Mancera, P. A., & Sánchez-García, I. (2003) · Oncogene · doi:10.1038/sj.onc.1206467 · Cited by 93
de Jong, M. C., ten Hoeve, J. J., Grenman, R. A., Wessels, L. F. A., Kerkhoven, R. H., Riele, H. T., van den Brekel, M. W. M., Verheij, M., & Begg, A. C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0454 · Cited by 91
Alba‐Castellón, L., Olivera‐Salguero, R., Mestre‐Farrera, A., Peña, R., Herrera, M., Bonilla, F., Casal, J. I., Baulida, J., Peña, C., & de Herreros, A. G. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0176 · Cited by 87
Zhang, J., Shen, C., Wang, L., Ma, Q., Xia, P., Qi, M., Yang, M., & Han, B. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.154 · Cited by 83
A core microRNA signature associated with inducers of the epithelial‐to‐mesenchymal transition
Díaz‐Martín, J., Díaz‐López, A., Moreno‐Bueno, G., Castilla, M. Á., Rosa-Rosa, J. M., Cano, A., & Palacios, J. (2013) · The Journal of Pathology · doi:10.1002/path.4289 · Cited by 78
Self-citationArai, K., Eguchi, T., Rahman, M. M., Sakamoto, R., Masuda, N., Nakatsura, T., Calderwood, S. K., Kozaki, K., & Itoh, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162394 · Cited by 78
Yamada, S., OKUMURA, N., Wei, L., Fuchs, B. C., Fujii, T., Sugimoto, H., Nomoto, S., Takeda, S., Tanabe, K. K., & Kodera, Y. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3779-2 · Cited by 77
In Vivo Visualization and Characterization of Epithelial–Mesenchymal Transition in Breast Tumors
Zhao, Z., Zhu, X., Cui, K., Mancuso, J. J., Federley, R., Fischer, K. R., Teng, G., Mittal, V., Gao, D., Zhao, H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2662 · Cited by 75
Zeb1 and S nail1 engage mi R ‐200f transcriptional and epigenetic regulation during EMT
Díaz‐López, A., Díaz‐Martín, J., Moreno‐Bueno, G., Cuevas, E. P., Santos, V., Olmeda, D., Portillo, F., Palacios, J., & Cano, A. (2014) · International Journal of Cancer · doi:10.1002/ijc.29177 · Cited by 73
Self-citationWang, C., Jiang, K., Kang, X., Gao, D., Sun, C., Li, Y., Sun, L., Zhang, S., Liu, X., Wu, W., et al. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.09.012 · Cited by 71
Barbazán, J., Muinelo‐Romay, L., Vieito, M., Candamio, S., Díaz‐López, A., Cano, A., Gómez‐Tato, A., de Cal, M. C., Abal, M., & López‐López, R. (2014) · International Journal of Cancer · doi:10.1002/ijc.28910 · Cited by 71
Self-citationMcInnes, L. M., Jacobson, N., Redfern, A. D., DOWLING, A. J., Thompson, E. W., & Saunders, C. M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00042 · Cited by 68
Li, X., Zhou, Y., Liu, Y., Zhang, X., Chen, T., Chen, K., Ba, Q., Li, J., Liu, H., & Wang, H. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.026 · Cited by 67
da Fonseca, L. M., da Silva, V. A., Freire‐de‐Lima, L., Previato, J. O., Mendonça‐Previato, L., & Capella, M. A. M. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00158 · Cited by 62
Liu, W., Vivian, C. J., Brinker, A. E., Hampton, K. R., Lianidou, E. S., & Welch, D. R. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0148-4 · Cited by 61
MicroRNAs and epithelial-mesenchymal transition in prostate cancer
Sekhon, K., Bucay, N., Majid, S., Dahiya, R., & Saini, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11708 · Cited by 61
Transforming growth factor-β in in vivo resistance
Teicher, B. A., Holden, S. A., Ara, G., & Chen, G. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050435 · Cited by 59
Kim, J., Hong, S. J., Park, J. Y., Park, J. H., Yu, Y. S., Park, S. Y., Lim, E. K., Choi, K. Y., Lee, E. K., Paik, S. S., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01536.x · Cited by 54
Geradts, J., de Herreros, A. G., Su, Z., Burchette, J. L., Broadwater, G., & Bachelder, R. E. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.11.004 · Cited by 51
Prognostic role of T wist or S nail in various carcinomas: a systematic review and meta‐analysis
Zhang, P., Hu, P., Shen, H., Yu, J., Liu, Q., & Du, J. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12343 · Cited by 45
Sesumi, Y., Suda, K., Mizuuchi, H., Kobayashi, Y., Sato, K., Chiba, M., Shimoji, M., Tomizawa, K., Takemoto, T., & Mitsudomi, T. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.12.012 · Cited by 45
A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome
Soundararajan, R., Paranjape, A. N., Barsan, V. V., Chang, J. T., & Mani, S. A. (2015) · Scientific Reports · doi:10.1038/srep11766 · Cited by 43
Distinct routes to metastasis: plasticity-dependent and plasticity-independent pathways
Somarelli, J. A., Schaeffer, D., Marengo, M. S., Bepler, T., Rouse, D. C., Ware, K. E., Hish, A. J., Zhao, Y. C., Buckley, A. F., Epstein, J. I., et al. (2016) · Oncogene · doi:10.1038/onc.2015.497 · Cited by 43
Metformin: A Rising Star to Fight the Epithelial Mesenchymal Transition in Oncology
Barrière, G., Tartary, M., & Rigaud, M. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611313020018 · Cited by 41
Aspirin, platelets, and cancer: The point of view of the internist
Santilli, F., Boccatonda, A., & Davì, G. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.06.004 · Cited by 41
Malek, R. A., Wang, H., Taparra, K., & Tran, P. T. (2017) · Cells Tissues Organs · doi:10.1159/000447238 · Cited by 41
Roop, R. P., Naughton, M. J., Poznak, C. H. V., Schneider, J. G., Lammers, P. E., Pluard, T., Johnson, F. C., Eby, C. S., & Weilbaecher, K. N. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2013.08.006 · Cited by 40
Fici, P., Gallerani, G., Morel, A., Mercatali, L., Ibrahim, T., Scarpi, E., Amadori, D., Puisieux, A., Rigaud, M., & Fabbri, F. (2016) · Oncotarget · doi:10.18632/oncotarget.13682 · Cited by 39
Zhang, J., Chen, Y.-L., Ji, G., Fang, W., Gao, Z., Liu, Y., Wang, J., Ding, X., & Gao, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064954 · Cited by 38
Epigenetics of epithelial‐to‐mesenchymal transition in pancreatic carcinoma
Träger, M. M., & Dhayat, S. A. (2017) · International Journal of Cancer · doi:10.1002/ijc.30626 · Cited by 38
Huang, J., Mei, H., Tang, Z., Li, J., Zhang, X., Lu, Y., Huang, F., Jin, Q., & Wang, Z. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.024 · Cited by 37
Okubo, K., Uenosono, Y., Arigami, T., Yanagita, S., Matsushita, D., Kijima, T., Amatatsu, M., Uchikado, Y., Kijima, Y., Maemura, K., et al. (2017) · Gastric Cancer · doi:10.1007/s10120-017-0705-x · Cited by 35
Phenotypic High-Throughput Screening Elucidates Target Pathway in Breast Cancer Stem Cell–Like Cells
Carmody, L., Germain, A. R., VerPlank, L., Nag, P. P., Muñoz, B., Perez, J. R., & Palmer, M. A. J. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112458317 · Cited by 30
Integrin-linked kinase activity modulates the pro-metastatic behavior of ovarian cancer cells
Bruney, L., Liu, Y., Grisoli, A., Ravosa, M. J., & Stack, M. S. (2016) · Oncotarget · doi:10.18632/oncotarget.7880 · Cited by 29
Zheng, Q., Xu, Y., Lu, J., Zhao, J., Wei, X., & Liu, P. (2016) · Reproductive Sciences · doi:10.1177/1933719116645192 · Cited by 25
Wang, X., Zhao, F., Shi, F., He, X., Pan, M., Wu, D., Li, M., Zhang, Y., & Dou, J. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.03.013 · Cited by 14
Tremblay, G., Malouin, M., Grothé, S., Kalbakji, A., Roy, S., Pagé, M., Paul‐Roc, B., Sulea, T. I., Lenferink, A. E. G., O'Connor‐McCourt, M. D., et al. (2010) · Cancer Research · doi:10.1158/1538-7445.am10-1467 · Cited by 2
Cited by
Guidelines and definitions for research on epithelial-mesenchymal transition
Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., Campbell, K., Cano, A., Casanova, J., Christofori, G., et al. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0237-9 · Cited by 2,226
Self-citationThe molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032
EMT, MET, Plasticity, and Tumor Metastasis
Bakir, B., Chiarella, A. M., Pitarresi, J. R., & Rustgi, A. K. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.07.003 · Cited by 1,010
Endothelial to Mesenchymal Transition in Cardiovascular Disease
Kovacic, J. C., Dimmeler, S., Harvey, R. P., Finkel, T., Aikawa, E., Krenning, G., & Baker, A. H. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.089 · Cited by 631
Non-redundant functions of EMT transcription factors
Stemmler, M. P., Eccles, R. L., Brabletz, S., & Brabletz, T. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0196-y · Cited by 524
Metadata
- Authors
- Santamaria, P. G., Moreno‐Bueno, G., Portillo, F., & Cano, A.
- Venue
- Molecular Oncology
- Publisher
- Wiley
- Published
- 2017-06-27
- Volume
- 11
- Issue
- 7
- Pages
- 718-738
- ISSN
- 1574-7891 (ISSN-L)
- 1878-0261
- OpenAlex
- W2621567555
- Cited by
- 259
- References
- 168
- FWCI
- 13.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.